Cancer clinical trials in the region Nouvelle-Aquitaine

322 currently recruiting clinical trials
Region Nouvelle-Aquitaine

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 2 3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR 1 Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3 Stomach and esophageal cancer #NCT06901531 #2024-519773-19-00
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 None Systemic Treatment-Naive CPS Positive (1 <= X < 5) CPS Positive (5 <= X < 10) CPS Positive (X >= 10)
HER2 Immunotherapy Chemotherapy
Institut Bergonié (Bordeaux), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Astellas Pharma Développement mondial, Inc.
Phase 3 Stomach and esophageal cancer #NCT06346197 #2023-506291-28-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic MSI/dMMR None Systemic Treatment-Naive CPS Positive (5 <= X < 10) CPS Positive (X >= 10)
HER2 Immunotherapy Immunotherapy
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Centre Léon Bérard
Phase 3 Lymphoma #NCT06091254
B cell lymphoma Follicular lymphoma None Systemic Treatment-Naive
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Regeneron Pharmaceuticals
Phase 3 Colon cancer Rectal cancer #NCT06252649 #2022-502352-31-00
Adenocarcinoma Metastatic KRAS G12C None Systemic Treatment-Naive
Targeted therapy Targeted therapy
CHU - Haut-Lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Amgen